← Back to Search

HIV/HCV Testing for Substance Use Disorder

N/A
Recruiting
Led By Lisa Metsch, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the period 7-12 months post site-randomization (t3).
Awards & highlights

Study Summary

This trial will test two active interventions to improve HIV testing and linkage to care among patients in substance use disorder treatment.

Who is the study for?
This trial is for opioid treatment programs (OTPs) that see at least 150 patients a year and can collect data on HIV/HCV testing and care. OTPs must be willing to share patient demographics, test reimbursement details, and have staff agree to participate in surveys and coaching.Check my eligibility
What is being tested?
The study tests two 'practice coaching' interventions aimed at improving HIV and HCV testing rates in OTPs. One focuses solely on HIV, while the other addresses both HIV/HCV. Their effectiveness will be compared with a control group receiving only information.See study design
What are the potential side effects?
Since this trial involves practice interventions rather than medications, there are no direct side effects like those associated with drugs. However, changes in clinic practices could affect patient experience or workflow.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the period 7-12 months post site-randomization (t3).
This trial's timeline: 3 weeks for screening, Varies for treatment, and the period 7-12 months post site-randomization (t3). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of OTP patients HIV tested at 6 months post intervention or control, while controlling for HIV testing during the baseline period (T1)
Secondary outcome measures
Proportion of OTP patients HIV tested at 12 months post intervention or control
Other outcome measures
OTPs' incremental cost-effectiveness ratio (ICER)

Trial Design

3Treatment groups
Experimental Treatment
Group I: Information Control GroupExperimental Treatment1 Intervention
The administrators of OTPs assigned to the control condition will receive a website link to and hard copy of the NIDA/SAMHSA Blending Initiative product for HIV rapid testing.
Group II: HIV and HCV Testing Practice Coaching Intervention GroupExperimental Treatment1 Intervention
The HIV and HCV Testing Practice Coaching (PC) Intervention will leverage the HIV PC intervention and follow the same interventional steps described above, and, in addition, provide information and training to support joint HIV/HCV testing and linkage to care among OTP patients.
Group III: HIV Testing Practice Coaching Intervention GroupExperimental Treatment1 Intervention
The HIV Testing Practice Coaching (PC) Intervention is designed to improve the provision and sustained implementation of on-site HIV testing and linkage to care among OTP patients.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityOTHER
2,266 Previous Clinical Trials
14,837,446 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,447,208 Total Patients Enrolled
Aspire Health PartnersUNKNOWN

Media Library

HIV and HCV Testing Practice Coaching Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03135886 — N/A
Substance Use Disorder Research Study Groups: HIV Testing Practice Coaching Intervention Group, HIV and HCV Testing Practice Coaching Intervention Group, Information Control Group
Substance Use Disorder Clinical Trial 2023: HIV and HCV Testing Practice Coaching Intervention Highlights & Side Effects. Trial Name: NCT03135886 — N/A
HIV and HCV Testing Practice Coaching Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03135886 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently participating in this research study?

"Affirmative. Records from clinicaltrials.gov demonstrate that this medical research is actively recruiting participants, starting on June 12th 2017 and the most recent update being made on June 16th 2023. 51 patients must be enrolled at one specific location."

Answered by AI

Is the enrollment phase for this trial still open?

"Per clinicaltrials.gov, the investigation is currently seeking participants; it was first made accessible on June 12th 2017 and last amended on June 16th 2023."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
Lisa Metsch 2017. "Project I Test: Implementing HIV Testing in Opioid Treatment Programs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03135886.
All > Opioid Dependence > Hepatitis C
~5 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top